📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. (2022)

First Author: Bennett C

Attributed to: The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021013113

PubMed Identifier: 35051265

Publication URI: http://europepmc.org/abstract/MED/35051265

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 14

ISSN: 0006-4971